Sorrentino R, Cirino G, Calignano A, Mancuso F, Sorrentino L, Andriuoli G, Pinto A
Department of Experimental Pharmacology, University of Naples Federico II, Italy.
J Cardiovasc Pharmacol. 1996 Oct;28(4):519-25. doi: 10.1097/00005344-199610000-00007.
Guinea pig aorta rings repeatedly stimulated with phenylephrine (1 microM) in the presence of Krebs solution containing ouabain (0.8 microM) or low K+ (0.5 mM) concentration produced an increase in basal tone. This effect is due to an increase in intracellular Ca2+ as a consequence of Na(+)-K+ATPase pump inhibition induced by receptorial (ouabain) or ion imbalance (low K+) mechanism. We investigated the effect of spironolactone and its metabolites canrenone and potassium canrenoate on the increase in basal tone of guinea pig aorta rings. Spironolactone, canrenone, and potassium canrenoate, in a concentration-dependent manner (3-30 microM), inhibited the increase in basal tone induced by ouabain, most likely acting as antagonist for ouabain binding site on Na(+)-K+ATPase pump. Indeed, this effect appears to be a feature of these drugs since structurally related drugs, such as aldosterone and hydrocortisone, were ineffective. Conversely, all the drugs tested reduced, to a certain degree, the increase in basal tone produced by low K+ Krebs solution, implying that this could be a non-specific effect. Our results may indicate that spironolactone, canrenone, and potassium canrenoate act in hypertension by interfering with mechanisms in which an ouabain-like factor is involved.
在含有哇巴因(0.8微摩尔)或低钾(0.5毫摩尔)浓度的 Krebs 溶液存在的情况下,用去氧肾上腺素(1微摩尔)反复刺激豚鼠主动脉环,可使基础张力增加。这种效应是由于受体(哇巴因)或离子失衡(低钾)机制诱导的钠钾ATP酶泵抑制导致细胞内钙离子增加所致。我们研究了螺内酯及其代谢产物坎利酮和坎利酸钾对豚鼠主动脉环基础张力增加的影响。螺内酯、坎利酮和坎利酸钾以浓度依赖性方式(3 - 30微摩尔)抑制哇巴因诱导的基础张力增加,很可能作为钠钾ATP酶泵上哇巴因结合位点的拮抗剂起作用。实际上,这种效应似乎是这些药物的一个特征,因为结构相关的药物,如醛固酮和氢化可的松,没有效果。相反,所有测试的药物都在一定程度上降低了低钾 Krebs 溶液产生的基础张力增加,这意味着这可能是一种非特异性效应。我们的结果可能表明,螺内酯、坎利酮和坎利酸钾通过干扰涉及类哇巴因因子的机制在高血压中发挥作用。